Insulinoma and Tuberous Sclerosis: A Possible Mechanistic Target of Rapamycin (mTOR) Pathway Abnormality?
Keyword(s):
Keyword(s):
2018 ◽
Vol 44
(1)
◽
pp. 6-17
◽
2013 ◽
Vol 591
(18)
◽
pp. 4611-4620
◽
2020 ◽
Vol 183
(3)
◽
pp. 588-589
◽
2018 ◽
Vol 836
◽
pp. 103-113
◽
Keyword(s):